Campos MI, Campos PS, Cangussu MC, Guimarães RC, Line SR Analysis of magnetic resonance imaging characteristics and pain in temporomandibular joints with and without degenerative changes of the condyle. Int J Oral Maxillofac Surg. 2008 Jun;37(6):529-34.
Disler DG, McCauley TR, Wirth CR, Fuchs MD Detection of knee hyaline cartilage defects using fat-suppressed three-dimensional spoiled gradient-echo MR imaging: comparison with standard MR imaging and correlation with arthroscopy. AJR Am J Roentgenol. 199
Dunn TC, Lu Y, Jin H, Ries MD, Majumdar S T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology. 2004 Aug;232(2):592-8. Epub 2004 Jun 23.
Eberhard D, Bantleon HP, Steger W Functional magnetic resonance imaging of temporomandibular joint disorders. Eur J Orthod. 2000 Oct;22(5):489-97.
Gibbs SJ, Simmons HC 3rd A protocol for magnetic resonance imaging of the temporomandibular joints. Cranio. 1998 Oct;16(4):236-41.
Güler N, Yatmaz PI, Ataoglu H, Emlik D, Uckan S Temporomandibular internal derangement: correlation of MRI findings with clinical symptoms of pain and joint sounds in patients with bruxing behaviour. Dentomaxillofac Radiol. 2003 Sep;32(5):304-10.
Hauger O, Dumont E, Chateil JF, Moinard M, Diard F Water excitation as an alternative to fat saturation in MR imaging: preliminary results in musculoskeletal imaging. Radiology. 2002 Sep;224(3):657-63.
Khan HA, Ahad H, Sharma P, Bajaj P, Hassan N, Kamal Y Correlation between magnetic resonance imaging and arthroscopic findings in the knee joint. Trauma Mon. 2015 Feb;20(1):e18635. doi: 10.5812/traumamon.18635. Epub 2015 Jan 7.
Larheim TA Role of magnetic resonance imaging in the clinical diagnosis of the temporomandibular joint. Cells Tissues Organs. 2005;180(1):6-21. Review.
Moncada G, Cortés D, Millas R, Marholz C Relationship between disk position and degenerative bone changes in temporomandibular joints of young subjects with TMD. An MRI study. J Clin Pediatr Dent. 2014 Spring;38(3):269-76.
Recht MP, Piraino DW, Paletta GA, Schils JP, Belhobek GH Accuracy of fat-suppressed three-dimensional spoiled gradient-echo FLASH MR imaging in the detection of patellofemoral articular cartilage abnormalities. Radiology. 1996 Jan;198(1):209-12.
Ren YF, Westesson PL, Isberg A Magnetic resonance imaging of the temporomandibular joint: value of pseudodynamic images. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Jan;81(1):110-23.
Stegenga B Osteoarthritis of the temporomandibular joint organ and its relationship to disc displacement. J Orofac Pain. 2001 Summer;15(3):193-205. Review.
Suenaga S, Ogura T, Matsuda T, Noikura T Severity of synovium and bone marrow abnormalities of the temporomandibular joint in early rheumatoid arthritis: role of gadolinium-enhanced fat-suppressed T1-weighted spin echo MRI. J Comput Assist Tomogr. 2000 M
Tanaka E, Detamore MS, Mercuri LG Degenerative disorders of the temporomandibular joint: etiology, diagnosis, and treatment. J Dent Res. 2008 Apr;87(4):296-307. Review.
Wang Y, Wluka AE, Jones G, Ding C, Cicuttini FM Use magnetic resonance imaging to assess articular cartilage. Ther Adv Musculoskelet Dis. 2012 Apr;4(2):77-97. doi: 10.1177/1759720X11431005.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
